Levchenko L I, Demchuk M L
Zh Vopr Neirokhir Im N N Burdenko. 1991 Jul-Aug(4):23-5.
Study of the content of products of lipid peroxidation, total lipid antioxidation activity, and superoxide dismutase activity in the tissue and blood of 31 patients (23 with gliomas and 8 with meningiomas) showed the level of malonic dialdehyde (MDA) in the tumor tissue to be significantly lower statistically than in the cerebral tissue. The MDA content was much lower in meningiomas than in gliomas. No essential differences were revealed in the MDA level in benign and malignant gliomas. This value correlated well with the total lipid antiperoxidation activity which was twice higher in tumor tissue than in the cerebral tissue and higher in meningiomas than in the tissue of gliomas. Superoxide dismutase activity was statistically significantly higher in the cerebral tissue than in all other tumor tissues studied. The blood plasma MDA level is higher in patients with gliomas than in the blood of donors while lipid antioxidation activity is lower. In the group of patients with meningiomas the blood plasma MDA level increases with reduction of superoxide dismutase activity, which may be evidence of its role in this process.
对31例患者(23例神经胶质瘤患者和8例脑膜瘤患者)的组织及血液中的脂质过氧化产物含量、总脂质抗氧化活性和超氧化物歧化酶活性进行研究,结果显示肿瘤组织中的丙二醛(MDA)水平在统计学上显著低于脑组织。脑膜瘤中的MDA含量远低于神经胶质瘤。在良性和恶性神经胶质瘤中,MDA水平未发现本质差异。该值与总脂质抗过氧化活性密切相关,肿瘤组织中的总脂质抗过氧化活性比脑组织高两倍,在脑膜瘤中比神经胶质瘤组织中的高。超氧化物歧化酶活性在脑组织中在统计学上显著高于所有其他研究的肿瘤组织。神经胶质瘤患者血浆中的MDA水平高于献血者血液中的,而脂质抗氧化活性则较低。在脑膜瘤患者组中,血浆MDA水平随超氧化物歧化酶活性降低而升高,这可能证明其在该过程中的作用。